• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Structure . Discovery and characterization of a pan-betacoronavirus S2-binding antibody

tetano

Editor, Senior Moderator
Structure


. 2024 Sep 15:S0969-2126(24)00369-1.
doi: 10.1016/j.str.2024.08.022. Online ahead of print. Discovery and characterization of a pan-betacoronavirus S2-binding antibody

Nicole V Johnson[SUP] 1 [/SUP], Steven C Wall[SUP] 2 [/SUP], Kevin J Kramer[SUP] 2 [/SUP], Clinton M Holt[SUP] 3 [/SUP], Sivakumar Periasamy[SUP] 4 [/SUP], Simone I Richardson[SUP] 5 [/SUP], Nelia P Manamela[SUP] 5 [/SUP], Naveenchandra Suryadevara[SUP] 6 [/SUP], Emanuele Andreano[SUP] 7 [/SUP], Ida Paciello[SUP] 7 [/SUP], Giulio Pierleoni[SUP] 7 [/SUP], Giulia Piccini[SUP] 8 [/SUP], Ying Huang[SUP] 9 [/SUP], Pan Ge[SUP] 10 [/SUP], James D Allen[SUP] 10 [/SUP], Naoko Uno[SUP] 11 [/SUP], Andrea R Shiakolas[SUP] 2 [/SUP], Kelsey A Pilewski[SUP] 2 [/SUP], Rachel S Nargi[SUP] 6 [/SUP], Rachel E Sutton[SUP] 6 [/SUP], Alexandria A Abu-Shmais[SUP] 2 [/SUP], Robert Parks[SUP] 12 [/SUP], Barton F Haynes[SUP] 13 [/SUP], Robert H Carnahan[SUP] 14 [/SUP], James E Crowe Jr[SUP] 15 [/SUP], Emanuele Montomoli[SUP] 16 [/SUP], Rino Rappuoli[SUP] 17 [/SUP], Alexander Bukreyev[SUP] 4 [/SUP], Ted M Ross[SUP] 18 [/SUP], Giuseppe A Sautto[SUP] 19 [/SUP], Jason S McLellan[SUP] 20 [/SUP], Ivelin S Georgiev[SUP] 21 [/SUP]



Affiliations
Abstract

The continued emergence of deadly human coronaviruses from animal reservoirs highlights the need for pan-coronavirus interventions for effective pandemic preparedness. Here, using linking B cell receptor to antigen specificity through sequencing (LIBRA-seq), we report a panel of 50 coronavirus antibodies isolated from human B cells. Of these, 54043-5 was shown to bind the S2 subunit of spike proteins from alpha-, beta-, and deltacoronaviruses. A cryoelectron microscopy (cryo-EM) structure of 54043-5 bound to the prefusion S2 subunit of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike defined an epitope at the apex of S2 that is highly conserved among betacoronaviruses. Although non-neutralizing, 54043-5 induced Fc-dependent antiviral responses in vitro, including antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP). In murine SARS-CoV-2 challenge studies, protection against disease was observed after introduction of Leu234Ala, Leu235Ala, and Pro329Gly (LALA-PG) substitutions in the Fc region of 54043-5. Together, these data provide new insights into the protective mechanisms of non-neutralizing antibodies and define a broadly conserved epitope within the S2 subunit.

Keywords: LALA-PG; LIBRA-seq; S2 subunit; antibodies; betacoronaviruses; coronaviruses; cryo-EM; spike protein.

 
Back
Top Bottom